Eye Catching Stocks: Navistar International Corporation (NYSE:NAV), Jinpan International Limited (NASDAQ:JST), Aratana Therapeutics, Inc. (NASDAQ:PETX), Cavium, Inc. (NASDAQ:CAVM), Micron Technology, Inc. (NASDAQ:MU)

On 27 July, Navistar International Corporation (NYSE:NAV) announced that it will be first-to-market with the Eaton Procision™ line of dual-clutch transmissions for its International® DuraStar® medium-duty trucks and IC Bus™ CE series school buses, available in late 2015. Based on Eaton’s testing, the new 7-speed transmissions deliver a significant fuel economy advantage compared to a similarly equipped vehicle with a torque converter automatic transmission. Navistar International Corporation (NYSE:NAV) belongs to Consumer Goods sector. Its net profit margin is -1.60% and weekly performance is -8.24%. On last trading day company shares ended up $16.14. Navistar International Corporation (NYSE:NAV) distance from 50-day simple moving average (SMA50) is -27.06%.

Jinpan International Limited (NASDAQ:JST) announced that the Company will present at the Jefferies 11th Annual Industrials Conference, to be held August 10-13, 2015 at the Grand Hyatt Hotel in New York City. Jinpan’s presentation is scheduled for Wednesday, August 12th, beginning at 3:20 p.m. ET. Jinpan International Limited (NASDAQ:JST) shares decreased -5.63% in last trading session and ended the day at $4.19. JST Gross Margin is 29.90% and its return on assets is 4.30%. Jinpan International Limited (NASDAQ:JST) quarterly performance is -11.60%.

Aratana Therapeutics, Inc. (NASDAQ:PETX) announced the positive results of a pilot field study of AT-002 (capromorelin) in cats. Capromorelin is a small molecule that mimics ghrelin, the naturally occurring hormone that stimulates appetite, increases body weight and increases serum growth hormone levels. On 04 August, Aratana Therapeutics, Inc. (NASDAQ:PETX) shares advanced 1.09% and was closed at $17.57. Aratana Therapeutics, Inc. (NASDAQ:PETX) year to date (YTD) performance is -1.40%.

On 30 July, Cavium, Inc. (NASDAQ:CAVM) announced financial results for the second quarter ended June 30, 2015.Net revenue in the second quarter of 2015 was $105.0 million, a 3.1% sequential increase from the $101.8 million reported in the first quarter of 2015 and a 15.8% year-over-year increase from the $90.7 million reported in the second quarter of 2014. Cavium, Inc. (NASDAQ:CAVM) ended the last trading day at $66.94. Company weekly volatility is calculated as 5.65% and price to cash ratio as 30.60. Cavium, Inc. (NASDAQ:CAVM) showed a weekly performance of 4.15%.

On 31 July, Micron Technology, Inc. (NASDAQ:MU) and Intel are starting production of a new, faster type of memory chip, which they say will change how computers access large amounts of data.Micron Technology, Inc. (NASDAQ:MU) shares advanced 0.05% in last trading session and ended the day at $19.01. MU Gross Margin is 33.50% and its return on assets is 15.20%. Micron Technology, Inc. (NASDAQ:MU) quarterly performance is -32.20%.

Leave a Reply

Your email address will not be published. Required fields are marked *